Thank you, Mr. Chairman, and through you, thank you to the witnesses.
First of all, I must say how refreshing it is to hear the new-found support of the nuclear industry from the New Democratic Party.
We've heard that even though there may be many reactors or other sources of moly-99, the bottleneck may really be the limited number of places where the radioactive targets can be received and processed to make the medical products. There must also be a challenge to find locations for the handling of the resulting radioactive waste. Can you tell us the role of Chalk River Laboratories, presently and in the foreseeable future, in providing these essential services as part of the supply chain for medical isotopes?